Source: Indian Pharma Post

Dr.Reddy's: Bio-Thera & Dr Reddy's execute commercialization pact for biosimilars Stelara & Simponi for SE Asia

Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Erez Israeli's photo - CEO of Dr.Reddy's

CEO

Erez Israeli

CEO Approval Rating

67/100

Read more